恒瑞医药注射用瑞康曲妥珠单抗获得美国FDA孤儿药资格认定

Core Viewpoint - Heng Rui Medicine announced that its injectable drug, Rui Kang Qu Mo Zhu Dan Kang, has received orphan drug designation from the U.S. Food and Drug Administration (FDA) [1] Group 1 - The drug is classified as an orphan drug, which is intended for the prevention, treatment, or diagnosis of rare diseases [1]